Myocardial Perfusion Imaging with Regadenoson and Sestamibi

Radiotracer Characteristics

• Sestamibi is a radiotracer used to visualize myocardial perfusion during imaging procedures, showing a linear relationship with coronary blood flow when administered intravenously, making it effective for detecting areas of reduced perfusion 1, 2
• Sestamibi has minimal redistribution over time, allowing delayed imaging after injection without significant change in the initial distribution pattern 2

Imaging Protocol and Dosage

• Sestamibi SPECT imaging typically takes approximately 40 minutes for image acquisition 2
• The typical effective radiation dose range for a 1-day Tc-99m rest-stress imaging protocol is 9.8 to 16.3 mSv 2

Diagnostic Accuracy

• Studies have shown high sensitivity (93%) and specificity (70%) for detecting myocardial infarction using sestamibi SPECT imaging 2

Clinical Application

• The combination of regadenoson stress with sestamibi imaging provides comprehensive assessment of coronary artery disease, including perfusion defects, as noted by the American College of Cardiology 1
• Sestamibi's minimal redistribution property allows for delayed imaging after stress, which is particularly useful in acutely ill patients, according to the American College of Cardiology 3

Imaging Modality

• Sestamibi's properties allow for SPECT imaging, which is generally more accurate than planar imaging for diagnosing coronary artery disease, as recommended by the American College of Cardiology 3, 4